GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Caution] CagriSema trial ratios are fixed-dose, do not extrapolate to self-mixing — 23 comments in the full submission. View in context.
401
c/cagrilintide·submitted 6 days ago by u/forest_plot_fiona

[Caution] CagriSema trial ratios are fixed-dose, do not extrapolate to self-mixing

Cautionbranch of 7 comments

CagriSema trial ratios are fixed-dose, do not extrapolate to self-mixing — a position I have arrived at slowly and would like tested. Reading the trial literature on this without misleading yourself. Separate the monotherapy arms from the combination arms before you do anything else. They report different effect…

Read the full submission and all 23 comments →

This branch

7 comments, started 4 days ago
u/lane_map_larrylogistics38 points·4 days ago

the monotherapy numbers are modest and that is not the point

replysharereportpermalink
u/titration_marshalmod · c/semaglutide0 points·4 days ago

the monotherapy numbers are modest and that is not the point

lane_map_larry is right that the evidence base here is thin. Conclusions should be held loosely.

replysharereportpermalink
u/sten_rautio1 point·4 days ago·edited

Yes. The combination is where the interesting effect sizes are, and the monotherapy arms read very differently.

replysharereportpermalink
u/pavel_halvorsen23 points·4 days ago

Went looking for independent results on this and found a handful across the whole site. That is the honest state of the evidence.

replysharereportpermalink
u/wrong_network_w0 points·3 days ago

Went looking for independent results on this and found a handful across the whole site.

Disagreeing with this line: that figure is from a combination arm and is being quoted as monotherapy.

replysharereportpermalink
u/ahmed_fonseca1 point·3 days ago

amylin analogue, different receptor family, different story

replysharereportpermalink
u/ilias_kaufmann-8 points·4 days ago

REDEFINE is the combination programme

replysharereportpermalink

← back to the whole thread

About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.